Abstract
Using a multiplexed, reporter gene-based, high-throughput screen, we identified 9-fluoro-7-hydroxy-3-methyl-5-oxo-N-(pyridin-3-ylmethyl)-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-6-carboxamide as a TLR2 agonist. Preliminary structure-activity relationship studies on the carboxamide moiety led to the identification of analogues that induce chemokines and cytokines in a TLR2-dependent manner. These results represent new leads for the development of vaccine adjuvants.
Original language | English (US) |
---|---|
Pages (from-to) | 132-136 |
Number of pages | 5 |
Journal | ACS Medicinal Chemistry Letters |
Volume | 10 |
Issue number | 1 |
DOIs | |
State | Published - Oct 1 2019 |
Bibliographical note
Funding Information:*Phone: (612) 625-3848. E-mail: [email protected]. ORCID Sunil A. David: 0000-0003-1655-4641 Author Contributions ‡These authors contributed equally. Funding This work was supported by NIH/NIAID contract HHSN272201400056C. Notes The authors declare no competing financial interest.
Keywords
- Toll-like receptor 2
- Vaccine adjuvants
- chemokines
- cytokines
- dihydropyridine-quinolones